{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:52:20Z","timestamp":1774126340109,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-022-02091-y","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T13:04:52Z","timestamp":1651755892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Human milk glycosaminoglycans inhibit cytomegalovirus and respiratory syncytial virus infectivity by impairing cell binding"],"prefix":"10.1038","author":[{"given":"Rachele","family":"Francese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Donalisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Ritt\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Capitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Maccari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Tonetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido E.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Bertino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"2091_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.earlhumdev.2015.08.013","volume":"91","author":"NJ Andreas","year":"2015","unstructured":"Andreas, N. J., Kampmann, B. & Mehring Le-Doare, K. Human breast milk: a review on its composition and bioactivity. Early Hum. Dev. 91, 629\u2013635 (2015).","journal-title":"Early Hum. Dev."},{"key":"2091_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pcl.2012.10.002","volume":"60","author":"O Ballard","year":"2013","unstructured":"Ballard, O. & Morrow, A. L. Human milk composition: nutrients and bioactive factors. Pediatr. Clin. North Am. 60, 49\u201374 (2013).","journal-title":"Pediatr. Clin. North Am."},{"key":"2091_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MCO.0000000000000466","volume":"21","author":"KG Eriksen","year":"2018","unstructured":"Eriksen, K. G., Christensen, S. H., Lind, M. V. & Michaelsen, K. F. Human milk composition and infant growth. Curr. Opin. Clin. Nutr. Metab. Care 21, 200\u2013206 (2018).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"2091_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/children8100863","volume":"8","author":"G Vizzari","year":"2021","unstructured":"Vizzari, G. et al. Human milk, more than simple nourishment. Children 8, 863 (2021).","journal-title":"Children"},{"key":"2091_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/nu13020694","volume":"13","author":"D Morniroli","year":"2021","unstructured":"Morniroli, D. et al. The antiviral properties of human milk: a multitude of defence tools from mother nature. Nutrients 13, 694 (2021).","journal-title":"Nutrients"},{"key":"2091_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/microorganisms9040715","volume":"9","author":"SIS Wedekind","year":"2021","unstructured":"Wedekind, S. I. S. & Shenker, N. S. Antiviral properties of human milk. Microorganisms 9, 715 (2021).","journal-title":"Microorganisms"},{"key":"2091_CR7","first-page":"419","volume":"125","author":"DS Newburg","year":"1995","unstructured":"Newburg, D. S., Linhardt, R. J., Ampofo, S. A. & Yolken, R. H. Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor. J. Nutr. 125, 419\u2013424 (1995).","journal-title":"J. Nutr."},{"key":"2091_CR8","doi-asserted-by":"publisher","first-page":"e0008713","DOI":"10.1371\/journal.pntd.0008713","volume":"14","author":"R Francese","year":"2020","unstructured":"Francese, R. et al. Anti-Zika virus and anti-Usutu virus activity of human milk and its components. PLoS Negl. Trop. Dis. 14, e0008713 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2091_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/pr.2015.262","volume":"79","author":"GV Coppa","year":"2016","unstructured":"Coppa, G. V. et al. Human milk glycosaminoglycans inhibit in vitro the adhesion of Escherichia coli and Salmonella fyris to human intestinal cells. Pediatr. Res. 79, 603\u2013607 (2016).","journal-title":"Pediatr. Res."},{"key":"2091_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/glycob\/cwq164","volume":"21","author":"GV Coppa","year":"2011","unstructured":"Coppa, G. V. et al. Composition and structure elucidation of human milk glycosaminoglycans. Glycobiology 21, 295\u2013303 (2011).","journal-title":"Glycobiology"},{"key":"2091_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/07853890510007340","volume":"37","author":"S Olofsson","year":"2005","unstructured":"Olofsson, S. & Bergstr\u00f6m, T. Glycoconjugate glycans as viral receptors. Ann. Med. 37, 154\u2013172 (2005).","journal-title":"Ann. Med."},{"key":"2091_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1824-7288-39-2","volume":"39","author":"GV Coppa","year":"2013","unstructured":"Coppa, G. V. et al. Human milk glycosaminoglycans: the state of the art and future perspectives. Ital. J. Pediatr. 39, 2 (2013).","journal-title":"Ital. J. Pediatr."},{"key":"2091_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/v11070596","volume":"11","author":"V Cagno","year":"2019","unstructured":"Cagno, V., Tseligka, E. D., Jones, S. T. & Tapparel, C. Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias? Viruses 11, 596 (2019).","journal-title":"Viruses"},{"key":"2091_CR14","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1093\/infdis\/jiz446","volume":"221","author":"N Kabani","year":"2020","unstructured":"Kabani, N. & Ross, S. A. Congenital cytomegalovirus infection. J. Infect. Dis. 221, S9\u2013S14 (2020).","journal-title":"J. Infect. Dis."},{"key":"2091_CR15","doi-asserted-by":"publisher","first-page":"e0261011","DOI":"10.1371\/journal.pone.0261011","volume":"16","author":"C P\u00e9rillaud-Dubois","year":"2021","unstructured":"P\u00e9rillaud-Dubois, C. et al. Current practices of management of maternal and congenital cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: systematic review. PLoS ONE 16, e0261011 (2021).","journal-title":"PLoS ONE"},{"key":"2091_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ppul.23570","volume":"52","author":"RT Stein","year":"2017","unstructured":"Stein, R. T. et al. Respiratory syncytial virus hospitalization and mortality: systematic review and meta-analysis. Pediatr. Pulmonol. 52, 556\u2013569 (2017).","journal-title":"Pediatr. Pulmonol."},{"key":"2091_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","volume":"45","author":"AT Borchers","year":"2013","unstructured":"Borchers, A. T., Chang, C., Gershwin, M. E. & Gershwin, L. J. Respiratory syncytial virus\u2014a comprehensive review. Clin. Rev. Allergy Immunol. 45, 331\u2013379 (2013).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2091_CR18","doi-asserted-by":"publisher","first-page":"e2003","DOI":"10.1002\/rmv.2003","volume":"28","author":"A Sadiq","year":"2018","unstructured":"Sadiq, A., Bostan, N., Yinda, K. C., Naseem, S. & Sattar, S. Rotavirus: genetics, pathogenesis and vaccine advances. Rev. Med. Virol. 28, e2003 (2018).","journal-title":"Rev. Med. Virol."},{"key":"2091_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clp.2016.11.012","volume":"44","author":"K Hamprecht","year":"2017","unstructured":"Hamprecht, K. & Goelz, R. Postnatal cytomegalovirus infection through human milk in preterm infants: transmission, clinical presentation, and prevention. Clin. Perinatol. 44, 121\u2013130 (2017).","journal-title":"Clin. Perinatol."},{"key":"2091_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/CMR.00062-12","volume":"26","author":"S Manicklal","year":"2013","unstructured":"Manicklal, S., Emery, V. C., Lazzarotto, T., Boppana, S. B. & Gupta, R. K. The \u2018silent\u2019 global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 26, 86\u2013102 (2013).","journal-title":"Clin. Microbiol. Rev."},{"key":"2091_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/08035250410022332","volume":"94","author":"S Doctor","year":"2005","unstructured":"Doctor, S. et al. Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr. 94, 53\u201358 (2005).","journal-title":"Acta Paediatr."},{"key":"2091_CR22","doi-asserted-by":"publisher","first-page":"e1937","DOI":"10.1542\/peds.2013-0076","volume":"131","author":"TM Lanzieri","year":"2013","unstructured":"Lanzieri, T. M., Dollard, S. C., Josephson, C. D., Schmid, D. S. & Bialek, S. R. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics 131, e1937\u2013e1945 (2013).","journal-title":"Pediatrics"},{"key":"2091_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/MPG.0000000000002071","volume":"67","author":"M Donalisio","year":"2018","unstructured":"Donalisio, M. et al. Anti-cytomegalovirus activity in human milk and colostrum from mothers of preterm infants. J. Pediatr. Gastroenterol. Nutr. 67, 654\u2013659 (2018).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"2091_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fped.2018.00304","volume":"6","author":"M Donalisio","year":"2018","unstructured":"Donalisio, M. et al. High temperature-short time pasteurization has a lower impact on the antiviral properties of human milk than Holder pasteurization. Front. Pediatr. 6, 304 (2018).","journal-title":"Front. Pediatr."},{"key":"2091_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/0890334420988239","volume":"37","author":"A Civra","year":"2021","unstructured":"Civra, A. et al. Human colostrum and derived extracellular vesicles prevent infection by human rotavirus and respiratory syncytial virus in vitro. J. Hum. Lact. 37, 122\u2013134 (2021).","journal-title":"J. Hum. Lact."},{"key":"2091_CR26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(97)10322-1","volume":"351","author":"DS Newburg","year":"1998","unstructured":"Newburg, D. S. et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 351, 1160\u20131164 (1998).","journal-title":"Lancet"},{"key":"2091_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1021\/acsinfecdis.0c00807","volume":"7","author":"RE Moore","year":"2021","unstructured":"Moore, R. E., Xu, L. L. & Townsend, S. D. Prospecting human milk oligosaccharides as a defense against viral infections. ACS Infect. Dis. 7, 254\u2013263 (2021).","journal-title":"ACS Infect. Dis."},{"key":"2091_CR28","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.3390\/molecules16086992","volume":"16","author":"F Berlutti","year":"2011","unstructured":"Berlutti, F. et al. Antiviral properties of lactoferrin\u2014a natural immunity molecule. Molecules 16, 6992\u20137018 (2011).","journal-title":"Molecules"},{"key":"2091_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14767058.2010.512414","volume":"23","author":"S Arslanoglu","year":"2010","unstructured":"Arslanoglu, S. et al. Guidelines for the establishment and operation of a donor human milk bank. J. Matern. Fetal Neonatal Med. 23, 1\u201320 (2010).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"2091_CR30","doi-asserted-by":"publisher","first-page":"E1087","DOI":"10.3390\/microorganisms8071087","volume":"8","author":"M Donalisio","year":"2020","unstructured":"Donalisio, M. et al. Extracellular vesicles in human preterm colostrum inhibit infection by human cytomegalovirus in vitro. Microorganisms 8, E1087 (2020).","journal-title":"Microorganisms"},{"key":"2091_CR31","doi-asserted-by":"publisher","unstructured":"Civra, A. et al. Modulation of cell proteome by 25-hydroxycholesterol and 27-hydroxycholesterol: a link between cholesterol metabolism and antiviral defense. Free Radic. Biol. Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.08.031 (2019).","DOI":"10.1016\/j.freeradbiomed.2019.08.031"},{"key":"2091_CR32","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.3168\/jds.2018-16016","volume":"102","author":"A Civra","year":"2019","unstructured":"Civra, A. et al. Colostrum from cows immunized with a veterinary vaccine against bovine rotavirus displays enhanced in vitro anti-human rotavirus activity. J. Dairy Sci. 102, 4857\u20134869 (2019).","journal-title":"J. Dairy Sci."},{"key":"2091_CR33","doi-asserted-by":"publisher","first-page":"113826","DOI":"10.1016\/j.jpba.2020.113826","volume":"195","author":"N Volpi","year":"2021","unstructured":"Volpi, N., Galeotti, F., Maccari, F., Capitani, F. & Mantovani, V. Structural definition of terrestrial chondroitin sulfate of various origin and repeatability of the production process. J. Pharm. Biomed. Anal. 195, 113826 (2021).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"2091_CR34","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1002\/jps.20997","volume":"96","author":"N Volpi","year":"2007","unstructured":"Volpi, N. Analytical aspects of pharmaceutical grade chondroitin sulfates. J. Pharm. Sci. 96, 3168\u20133180 (2007).","journal-title":"J. Pharm. Sci."},{"key":"2091_CR35","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1021\/ac201426e","volume":"83","author":"F Galeotti","year":"2011","unstructured":"Galeotti, F. & Volpi, N. Online reverse phase-high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry separation and characterization of heparan sulfate, heparin, and low-molecular weight-heparin disaccharides derivatized with 2-aminoacridone. Anal. Chem. 83, 6770\u20136777 (2011).","journal-title":"Anal. Chem."},{"key":"2091_CR36","doi-asserted-by":"publisher","first-page":"e1700679","DOI":"10.1002\/mnfr.201700679","volume":"62","author":"V Morozov","year":"2018","unstructured":"Morozov, V., Hansman, G., Hanisch, F.-G., Schroten, H. & Kunz, C. Human milk oligosaccharides as promising antivirals. Mol. Nutr. Food Res. 62, e1700679 (2018).","journal-title":"Mol. Nutr. Food Res."},{"key":"2091_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/978-1-4757-4242-8_69","volume":"554","author":"M Viveros-Rogel","year":"2004","unstructured":"Viveros-Rogel, M., Soto-Ramirez, L., Chaturvedi, P., Newburg, D. S. & Ruiz-Palacios, G. M. Inhibition of HIV-1 infection in vitro by human milk sulfated glycolipids and glycosaminoglycans. Adv. Exp. Med. Biol. 554, 481\u2013487 (2004).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2091_CR38","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1128\/JVI.74.14.6442-6447.2000","volume":"74","author":"SA Feldman","year":"2000","unstructured":"Feldman, S. A., Audet, S. & Beeler, J. A. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J. Virol. 74, 6442\u20136447 (2000).","journal-title":"J. Virol."},{"key":"2091_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.coviro.2012.01.001","volume":"2","author":"AL Vanarsdall","year":"2012","unstructured":"Vanarsdall, A. L. & Johnson, D. C. Human cytomegalovirus entry into cells. Curr. Opin. Virol. 2, 37\u201342 (2012).","journal-title":"Curr. Opin. Virol."},{"key":"2091_CR40","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1006\/viro.1993.1192","volume":"193","author":"T Compton","year":"1993","unstructured":"Compton, T., Nowlin, D. M. & Cooper, N. R. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193, 834\u2013841 (1993).","journal-title":"Virology"},{"key":"2091_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-14741-9_3","volume":"1215","author":"JM Rodr\u00edguez","year":"2019","unstructured":"Rodr\u00edguez, J. M. & Luque, D. Structural insights into rotavirus entry. Adv. Exp. Med. Biol. 1215, 45\u201368 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2091_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000330848","volume":"101","author":"GV Coppa","year":"2012","unstructured":"Coppa, G. V. et al. Glycosaminoglycan content in term and preterm milk during the first month of lactation. Neonatology 101, 74\u201376 (2012).","journal-title":"Neonatology"},{"key":"2091_CR43","doi-asserted-by":"publisher","unstructured":"Rusnati, M. & Lembo, D. Heparan sulfate proteoglycans: a multifaceted target for novel approaches in antiviral drug discovery. J. Bioeng. Biomed. Sci. https:\/\/doi.org\/10.4172\/2155-9538.1000177 (2016).","DOI":"10.4172\/2155-9538.1000177"},{"key":"2091_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pharmthera.2009.05.001","volume":"123","author":"M Rusnati","year":"2009","unstructured":"Rusnati, M. et al. Sulfated K5 Escherichia coli polysaccharide derivatives: a novel class of candidate antiviral microbicides. Pharmacol. Ther. 123, 310\u2013322 (2009).","journal-title":"Pharmacol. Ther."},{"key":"2091_CR45","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1128\/JVI.01362-16","volume":"90","author":"EM Klimyte","year":"2016","unstructured":"Klimyte, E. M., Smith, S. E., Oreste, P., Lembo, D. & Dutch, R. E. Inhibition of human metapneumovirus binding to heparan sulfate blocks infection in human lung cells and airway tissues. J. Virol. 90, 9237\u20139250 (2016).","journal-title":"J. Virol."},{"key":"2091_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejpb.2014.05.007","volume":"88","author":"D Lembo","year":"2014","unstructured":"Lembo, D. et al. Auto-associative heparin nanoassemblies: a biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSV. Eur. J. Pharm. Biopharm. 88, 275\u2013282 (2014).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2091_CR47","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1128\/AAC.00443-15","volume":"59","author":"V Cagno","year":"2015","unstructured":"Cagno, V. et al. The agmatine-containing poly(amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses. Antimicrob. Agents Chemother. 59, 5250\u20135259 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2091_CR48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.antiviral.2011.03.176","volume":"90","author":"V Pirrone","year":"2011","unstructured":"Pirrone, V., Wigdahl, B. & Krebs, F. C. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1. Antivir. Res. 90, 168\u2013182 (2011).","journal-title":"Antivir. Res."},{"key":"2091_CR49","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1099\/00222615-47-11-1015","volume":"47","author":"J Portelli","year":"1998","unstructured":"Portelli, J., Gordon, A. & May, J. T. Effect of compounds with antibacterial activities in human milk on respiratory syncytial virus and cytomegalovirus in vitro. J. Med. Microbiol. 47, 1015\u20131018 (1998).","journal-title":"J. Med. Microbiol."},{"key":"2091_CR50","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1099\/0022-1317-49-8-719","volume":"49","author":"NM Clarke","year":"2000","unstructured":"Clarke, N. M. & May, J. T. Effect of antimicrobial factors in human milk on rhinoviruses and milk-borne cytomegalovirus in vitro. J. Med. Microbiol. 49, 719\u2013723 (2000).","journal-title":"J. Med. Microbiol."},{"key":"2091_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1006\/viro.2000.0293","volume":"271","author":"LK Hallak","year":"2000","unstructured":"Hallak, L. K., Collins, P. L., Knudson, W. & Peeples, M. E. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271, 264\u2013275 (2000).","journal-title":"Virology"},{"key":"2091_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10719-016-9655-5","volume":"33","author":"F Maccari","year":"2016","unstructured":"Maccari, F. et al. Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. Glycoconj. J. 33, 181\u2013188 (2016).","journal-title":"Glycoconj. J."},{"key":"2091_CR53","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/MPG.0b013e3182a3af0a","volume":"57","author":"ESPGHAN Committee on Nutrition","year":"2013","unstructured":"ESPGHAN Committee on Nutrition et al. Donor human milk for preterm infants: current evidence and research directions. J. Pediatr. Gastroenterol. Nutr. 57, 535\u2013542 (2013).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"Suppl 2","key":"2091_CR54","first-page":"1","volume":"23","author":"Italian Association of Human Milk Banks Associazione Italiana Banche del Latte Umano Donato","year":"2010","unstructured":"Italian Association of Human Milk Banks Associazione Italiana Banche del Latte Umano Donato et al. Guidelines for the establishment and operation of a donor human milk bank. J. Matern. Fetal Neonatal Med. 23(Suppl 2), 1\u201320 (2010).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"2091_CR55","doi-asserted-by":"crossref","unstructured":"Peila, C. et al. The effect of Holder pasteurization on nutrients and biologically-active components in donor human milk: a review. Nutrients 8, 477 (2016).","DOI":"10.3390\/nu8080477"},{"key":"2091_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/MPG.0000000000000570","volume":"60","author":"A Coscia","year":"2015","unstructured":"Coscia, A. et al. Effect of holder pasteurisation on human milk glycosaminoglycans. J. Pediatr. Gastroenterol. Nutr. 60, 127\u2013130 (2015).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"2091_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.foodchem.2018.03.076","volume":"258","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Glycosaminoglycanomic profiling of human milk in different stages of lactation by liquid chromatography-tandem mass spectrometry. Food Chem. 258, 231\u2013236 (2018).","journal-title":"Food Chem."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02091-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T21:04:31Z","timestamp":1651784671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02091-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":57,"alternative-id":["2091"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02091-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}